|
|
|
|
|
|
by serf
1214 days ago
|
|
|
if someone is 'losing glycemic control' because they can't get a specific new en-vogue med, then their doctor is doing a poor job. there is a very big problem with blaming the suffering who find relief with this drug -- regardless of what their ailment is -- rather than blaming the systems and processes that lead to a supposed shortage that urged a price adjustment. forgive me for diving into conspiracy for a second here.. do you really think for a second that the pharmaceutical groups responsible for this class of drug do not have the facilities to ramp up production? They absolutely do -- the problem here is that since it's a gold-mine there is even more cash capture to occur with an added scarcity element, hence the price adjustment. The price adjustment wasn't to champion the diabetics over the obese, it was to make more MONEY. |
|
|
This is not a new hotness. And many diabetics have used this drug class for a long time.
And yeah, you're jumping into conspiracy theory. Ramping up production would likely take significant investment. Do they have the resources? Probably. But given the weight loss benefit is temporary (seriously, it is, ask anyone who has used one of these drugs for a significant amount of time), do you think they're going to sink significant investment into production when demand is going to wane in a few years? Well, you see, their investors are going to say no, and they hold the final say.